AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.

about

AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.

Item

http://www.wikidata.org/entity/Q38760655

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.

@en

type

Item

label

AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.

@en

prefLabel

AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.

@en

P1476

AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.

@en

P2093

Alexandre V Ivachtchenko

http://www.w3.org/2001/XMLSchema#string

Andrey Ivashchenko

http://www.w3.org/2001/XMLSchema#string

Angela Koryakova

http://www.w3.org/2001/XMLSchema#string

Ilya Okun

http://www.w3.org/2001/XMLSchema#string

Ramiz Salimov

http://www.w3.org/2001/XMLSchema#string

Ruben Karapetyan

http://www.w3.org/2001/XMLSchema#string

Vladimir Aladinskiy

http://www.w3.org/2001/XMLSchema#string

Yan Ivanenkov

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat

Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats

Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications

Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease

The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease

Family-based association study of the serotonin-6 receptor gene (C267T polymorphism) in schizophrenia

Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders

5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease

Serotonin 5-HT6 receptor antagonists for the treatment of Alzheimer's disease

Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used for the detection of cognitive enhancement and antipsychotic-like activity

P304

1043-1063

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-161262

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

O D Mitkin

P577

2017-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28550249

http://www.w3.org/2001/XMLSchema#string